Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Amortizatization of Intangibles: 2023-2025

Historic Amortizatization of Intangibles for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to -$201,000.

  • CG Oncology's Amortizatization of Intangibles fell 112.71% to -$201,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $710,000, marking a year-over-year decrease of 90.79%. This contributed to the annual value of $5.0 million for FY2024, which is 73.63% up from last year.
  • Per CG Oncology's latest filing, its Amortizatization of Intangibles stood at -$201,000 for Q3 2025, which was down 110.65% from $1.9 million recorded in Q2 2025.
  • CG Oncology's 5-year Amortizatization of Intangibles high stood at $2.5 million for Q2 2024, and its period low was -$1.3 million during Q4 2024.
  • For the 3-year period, CG Oncology's Amortizatization of Intangibles averaged around $1.1 million, with its median value being $1.5 million (2023).
  • Data for CG Oncology's Amortizatization of Intangibles shows a peak YoY increase of 37.33% (in 2024) and a maximum YoY decrease of 185.61% (in 2024) over the last 5 years.
  • CG Oncology's Amortizatization of Intangibles (Quarterly) stood at $1.5 million in 2023, then crashed by 185.61% to -$1.3 million in 2024, then slumped by 112.71% to -$201,000 in 2025.
  • Its Amortizatization of Intangibles was -$201,000 in Q3 2025, compared to $1.9 million in Q2 2025 and $279,000 in Q1 2025.